News on Trial Management Group Inc from BioPortfolio.com http://www.BioPortfolio.com Consolidated Trial Management Group Inc news from BioPortfolio.com Wed, 10 Feb 2010 16:17:46 GMT en SIRO Clinpharm announces alliance with DreamCIS CROhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039656&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Trial%20Management%20Group%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039656&THISHREF=http://c.moreover.com/click/here.pl%3fz2538296325%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039656&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Trial%20Management%20Group%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039656&THISHREF=http://c.moreover.com/click/here.pl%3fz2538296325%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Nyer Medical Group, Inc., Announces Voluntary Delisting From NASDAQ and Closings of Sales of Assetshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042218&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Trial%20Management%20Group%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042218&THISHREF=http://c.moreover.com/click/here.pl%3fz2539361924%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042218&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Trial%20Management%20Group%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042218&THISHREF=http://c.moreover.com/click/here.pl%3fz2539361924%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comKSLA: State: Birth defect rate in CA town not unusualhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039270&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Trial%20Management%20Group%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039270&THISHREF=http://c.moreover.com/click/here.pl%3fz2537992641%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039270&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Trial%20Management%20Group%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039270&THISHREF=http://c.moreover.com/click/here.pl%3fz2537992641%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comResearch & Development: IBM Introduces Power7 Familyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040441&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Trial%20Management%20Group%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040441&THISHREF=http://c.moreover.com/click/here.pl%3fz2538740117%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040441&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Trial%20Management%20Group%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040441&THISHREF=http://c.moreover.com/click/here.pl%3fz2538740117%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBio-IT World: More Big Pharma Research Cutshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040440&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Trial%20Management%20Group%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040440&THISHREF=http://c.moreover.com/click/here.pl%3fz2538739976%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040440&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Trial%20Management%20Group%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040440&THISHREF=http://c.moreover.com/click/here.pl%3fz2538739976%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBio-IT World: 2/10/10 - Ampyra is First Symptom Management Drug Developed Specifically to Treat MS, the First Oral MS Theraphttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042478&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Trial%20Management%20Group%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042478&THISHREF=http://c.moreover.com/click/here.pl%3fz2539432005%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042478&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Trial%20Management%20Group%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042478&THISHREF=http://c.moreover.com/click/here.pl%3fz2539432005%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Ampyra is First Symptom Management Drug Developed Specifically to Treat MS, the First Oral MS Therapy Approvedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041556&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Trial%20Management%20Group%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041556&THISHREF=http://c.moreover.com/click/here.pl%3fz2539164521%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041556&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Trial%20Management%20Group%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041556&THISHREF=http://c.moreover.com/click/here.pl%3fz2539164521%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: State invests $3 million in bioscience fundhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038899&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Trial%20Management%20Group%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038899&THISHREF=http://c.moreover.com/click/here.pl%3fz2537827787%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038899&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Trial%20Management%20Group%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038899&THISHREF=http://c.moreover.com/click/here.pl%3fz2537827787%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comOrlando Sentinel: The Role Of Online Social Networks In Preparing And Coping With Emergencieshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042848&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Trial%20Management%20Group%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042848&THISHREF=http://c.moreover.com/click/here.pl%3fz2539534014%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042848&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Trial%20Management%20Group%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042848&THISHREF=http://c.moreover.com/click/here.pl%3fz2539534014%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: Role of online social network in emergency managementhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042102&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Trial%20Management%20Group%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042102&THISHREF=http://c.moreover.com/click/here.pl%3fz2539316841%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042102&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Trial%20Management%20Group%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042102&THISHREF=http://c.moreover.com/click/here.pl%3fz2539316841%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Management of Severe Cleft and Syndromic Midface Hypoplasiahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041095&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Trial%20Management%20Group%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041095&THISHREF=http://c.moreover.com/click/here.pl%3fz2538999336%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041095&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Trial%20Management%20Group%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041095&THISHREF=http://c.moreover.com/click/here.pl%3fz2538999336%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: Selective IgA Deficiency in Children: Clinical Manifestations, Evaluation, and Managementhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040999&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Trial%20Management%20Group%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040999&THISHREF=http://c.moreover.com/click/here.pl%3fz2538960975%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040999&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Trial%20Management%20Group%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040999&THISHREF=http://c.moreover.com/click/here.pl%3fz2538960975%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comConsultant Live: New webinar to discuss financial and performance-related implications of medical homeshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040040&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Trial%20Management%20Group%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040040&THISHREF=http://c.moreover.com/click/here.pl%3fz2538544083%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040040&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Trial%20Management%20Group%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040040&THISHREF=http://c.moreover.com/click/here.pl%3fz2538544083%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Handling emergencies onlinehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039429&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Trial%20Management%20Group%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039429&THISHREF=http://c.moreover.com/click/here.pl%3fz2538111808%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039429&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Trial%20Management%20Group%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039429&THISHREF=http://c.moreover.com/click/here.pl%3fz2538111808%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Illumina Outlines Software Rollout Plans for 2010; Works on Several Fronts to Ease Data Managementhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039347&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Trial%20Management%20Group%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039347&THISHREF=http://c.moreover.com/click/here.pl%3fz2538046303%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039347&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Trial%20Management%20Group%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039347&THISHREF=http://c.moreover.com/click/here.pl%3fz2538046303%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenomeWeb: